TY - JOUR
T1 - Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance
AU - Sono, Tiyani Milta
AU - Yeika, Eugene
AU - Cook, Aislinn
AU - Kalungia, Aubrey
AU - Opanga, Sylvia A.
AU - Acolatse, ,Joseph Elikem Efui
AU - Sefah, Israel Abebrese
AU - Jelić, Ana Golić
AU - Campbell, Stephen
AU - Lorenzetti, Giulia
AU - Mustafa, Zia Ul
AU - Marković-Peković, Vanda
AU - Kurdi, Amanj
AU - Paramadhas, Bene D Anand
AU - Rwegerera, Godfrey Mutashambara
AU - Amu, Adefolarin A
AU - Alabi, Mobolaji Eniola
AU - Wesangula, Evelyn
AU - Oluka, Margaret
AU - Khuluza, Felix
AU - Chikowe, Ibrahim
AU - Fadare, Joseph O.
AU - Ogunleye, Olayinka O.
AU - Kibuule, Dan
AU - Hango, Ester
AU - Schellack, Natalie
AU - Ramdas, Nishana
AU - Massele, Amos
AU - Mudenda, Steward
AU - Hoxha, Iris
AU - Moore, Catrin E.
AU - Godman, Brian
AU - Meyer, Johanna C.
PY - 2023/10/27
Y1 - 2023/10/27
N2 - Introduction: Antimicrobial resistance (AMR) is a global concern. Currently, the greatest mortality due to AMR is in Africa. A key driver continues to be high levels of dispensing of antibiotics without a prescription. Areas covered: A need to document current rates of dispensing, their rationale and potential ways forward including antimicrobial stewardship programmes (ASPs). A narrative review was undertaken. The highest rates of antibiotic purchasing were in Eritrea (up to 89.2% of antibiotics dispensed), Ethiopia (up to 87.9%), Nigeria (up to 86.5%), Tanzania (up to 92.3%) and Zambia (up to 100% of pharmacies dispensing without a prescription). However, considerable variation with no dispensing in a minority of countries and situations. Key drivers of self-purchasing included high co-payment levels for physician consultations and antibiotic costs, travel costs, convenience of pharmacies, patient requests, limited knowledge of antibiotics and AMR and weak enforcement. ASPs have been introduced in some African countries along with quality targets to reduce inappropriate dispensing, centring on educating pharmacists and patients. Expert Opinion: ASP activities need accelerating among community pharmacies alongside quality targets, with greater monitoring of pharmacists’ activities to reduce inappropriate dispensing. Such activities, alongside educating patients and HCPs, should enhance appropriate dispensing of antibiotics and reduce AMR.
AB - Introduction: Antimicrobial resistance (AMR) is a global concern. Currently, the greatest mortality due to AMR is in Africa. A key driver continues to be high levels of dispensing of antibiotics without a prescription. Areas covered: A need to document current rates of dispensing, their rationale and potential ways forward including antimicrobial stewardship programmes (ASPs). A narrative review was undertaken. The highest rates of antibiotic purchasing were in Eritrea (up to 89.2% of antibiotics dispensed), Ethiopia (up to 87.9%), Nigeria (up to 86.5%), Tanzania (up to 92.3%) and Zambia (up to 100% of pharmacies dispensing without a prescription). However, considerable variation with no dispensing in a minority of countries and situations. Key drivers of self-purchasing included high co-payment levels for physician consultations and antibiotic costs, travel costs, convenience of pharmacies, patient requests, limited knowledge of antibiotics and AMR and weak enforcement. ASPs have been introduced in some African countries along with quality targets to reduce inappropriate dispensing, centring on educating pharmacists and patients. Expert Opinion: ASP activities need accelerating among community pharmacies alongside quality targets, with greater monitoring of pharmacists’ activities to reduce inappropriate dispensing. Such activities, alongside educating patients and HCPs, should enhance appropriate dispensing of antibiotics and reduce AMR.
KW - Africa
KW - antibiotics
KW - antimicrobial resistance
KW - antimicrobial stewardship programmes
KW - AWaRe classification
KW - community pharmacies
KW - health policy
KW - over-the-counter purchasing
KW - quality indicators
KW - utilisation patterns
U2 - 10.1080/14787210.2023.2259106
DO - 10.1080/14787210.2023.2259106
M3 - Article
SN - 1478-7210
VL - 21
SP - 1025
EP - 1055
JO - Expert Review of Anti-infective Therapy
JF - Expert Review of Anti-infective Therapy
IS - 10
ER -